Choose   Change
sentis-bgi-slide

Sentis™ – Cancer screening and personalized cancer therapies

Next Generation Sequencing has dramatically increased our knowledge of the genetic pathways involved in cancer. This allows for screening of genes closely associated with the incidence of particular cancers.

The Sentis™ Hereditary Breast and Ovarian Cancer Screen provides health providers and patients with information relating to 21 genes, which have been linked to Breast Cancer or Ovarian Cancer, including the tumor suppressor genes BRCA1/2.

This enables the development of patient-specific medical management plans that can prevent or delay the onset of cancer, or detect it at an earlier and more treatable stage.

Email info@bgi.com to learn how you can become a provider.

Contact

Don’t hesitate to contact us to request a quote or to talk more about your requirements and how we can support your needs.


(+45) 80 300 800 (Europe)
(+1) 617 500 2741 (Americas)
(+852) 36103510 (Asia Pacific)
(+86) 755 25273698 (China)



BGI certificates

Regional Availability

Testing services not currently available in the United States of America. In some markets, testing services are offered for research use only. Please contact a representative for regional availability.

Copyright © BGI 2016